According to reports from Page Six, the Duke and Duchess of Sussex checked into the Carlyle hotel in Manhattan on Wednesday, September 22.
The couple are in town for an appearance at Global Citizen Live in Central Park on Saturday and they will reportedly be enjoying a stay at the luxury hotel that was beloved by Prince Harry’s late mother.
Diana is said to have stayed in the Royal Suite during her visits, an 1,800-square-foot pad on the building’s 22nd floor, which now costs upwards of $8,000 a night. Prince William and Kate Middleton apparently stayed in the same room during a visit to the Big Apple in 2014.
Multiple sources told Page Six that the Sussexes are not staying in the Royal Suite.
According to Insider, the Carlyle is known for being a secret hideout for high profile guests as the staff are “famously close-lipped,” about what goes on inside the 188-room hotel.
It’s no surprise that the royals would flock to the discreet hotel, which is known for giving its guests privacy. It was even dubbed as the “Palace of Secrets,” as it leaves you “wishing the walls could talk,” per the hotel’s managing director Giovanni Beretta.
Harry and Meghan have already gotten down to business while spending time in the big city. On Thursday, September 23, they began their trip by visiting One World Observatory at the World Trade Center.
They were accompanied by Mayor Bill de Blasio, his wife Chirlane McCray, and their son Dante de Blasio. Kathy Hochel, the replacement of disgraced governor Andrew Cuomo, also tagged along for the outing.
As OK! previously reported, Prince Harry will be making an appearance at Global Citizen Live to discuss the importance of the COVID-19 vaccine.
“The Global Citizen Live campaign is calling on G7 countries (the world’s wealthiest nations) and the European Union to immediately share at least 1 billion COVID-19 vaccine doses with those most in need and support calls for a waiver on COVID-19 vaccine intellectual property rights. The campaign is also calling on Pfizer, BioNTech, and Moderna to share mRNA technology with the new World Health Organization-backed transfer hub based in South Africa,” according to the website.